Accelevir Diagnostics

company

About

Accelevir Diagnostics is a biotechnology company developing innovative assays for ultra-rare analytes in infectious diseases and beyond.

  • 1 - 10

Details

Last Funding Type
Grant
Last Funding Money Raised
$224.55K
Industries
Biotechnology
Founded date
Jan 1, 2015
Number Of Employee
1 - 10
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
2
$1.42M
Accelevir Diagnostics has raised a total of $1.42M in funding over 2 rounds. Their latest funding was raised on Sep 18, 2017 from a Grant round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Sep 18, 2017 Grant $1.19M 1 National Science Foundation Detail
Jun 24, 2016 Grant $224.55K 1 National Science Foundation Detail

Investors

Number of Lead Investors
Number of Investors
2
1
Accelevir Diagnostics is funded by 1 investors. National Science Foundation are the most recent investors.
Investor Name Lead Investor Funding Round
National Science Foundation Yes Grant